View Older Stories View More Recent Stories

Mar 8, 2022 09:00AM Mustang Bio Completes a $75 Million Debt Financing with Runway Growth Capital
Mar 8, 2022 09:00AM Mustang Bio Completes a $75 Million Debt Financing with Runway Growth Capital
Mar 8, 2022 07:59AM Iris Energy Limited Announces Monthly Investor Update for February 2022
Mar 8, 2022 07:59AM Iris Energy Limited Announces Monthly Investor Update for February 2022
Mar 8, 2022 07:30AM SatixFy to Go Public via Combination with Endurance Acquisition Corp. (EDNC)
Mar 8, 2022 07:30AM SatixFy, a Leader in Next-Generation Satellite Communication Systems, to Go Public via Combination with Endurance Acquisition Corp.
Mar 8, 2022 05:58AM Cantor Fitzgerald Reiterates Cidara Therapeutics (CDTX) at Overweight, Believes the Street Underappreciates Company's Sales Potential, Sees Upward Earnings Revisions
Mar 7, 2022 08:32AM Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination
Mar 7, 2022 08:00AM Brooklyn ImmunoTherapeutics Announces $12 Million Private Placement
Mar 7, 2022 07:59AM Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, $5 PT, VitaCare Sale is Good News, Priced Above Expectation, Increases Confidence in the Stock
Mar 7, 2022 07:36AM Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight, Newest Data Supports Positive Thesis for Stock
Mar 4, 2022 04:05PM Atlantic Coastal Acquisition Corp. II Announces the Separate Trading of its Shares of Series A Common Stock and Warrants Commencing March 7, 2022
Mar 4, 2022 06:36AM Cantor Fitzgerald Reiterates Overweight Rating on Evolus (EOLS), Jeuveau's Value Proposition is Underappreciated
Mar 4, 2022 06:35AM Curaleaf (CURLF) PT Lowered to $15.50 at Cantor Fitzgerald
Mar 4, 2022 06:34AM Hexo Corp. (HEXO:CN) (HEXO) PT Lowered to Cdn$0.90 at Cantor Fitzgerald
Mar 3, 2022 02:53PM Cantor Fitzgerald Reiterates Hutchison China MediTech Ltd. (HCM) at Overweight, Believes HCM's Pipeline is Underappreciated
Mar 3, 2022 02:07PM Cantor Fitzgerald Reiterates EyePoint (EYPT) at Overweight, Believes Potential Peak Sales for EYP-1901 Remains Underappreciated
Mar 3, 2022 12:21PM Cantor Fitzgerald Reiterates Entasis Therapeutics (ETTX) at Overweight, Believes More Value to Unlocked in Shares
Mar 3, 2022 06:08AM Form 8-K Cantor Fitzgerald Income For: Mar 01
Mar 2, 2022 04:46PM McEwen Mining Closes Flow-Through Financing
Mar 2, 2022 04:46PM McEwen Mining Closes Flow-Through Financing
Mar 2, 2022 10:56AM Cantor Fitzgerald Reiterates Avalo (AVTX) at Overweight, Peak Sales Potential of Pipeline is Underappreciated
Mar 2, 2022 08:01AM Graphite Corp. (GRPH) Appoints Alethia Young as Chief Financial Officer
Mar 2, 2022 08:00AM Graphite Bio Appoints Alethia Young as Chief Financial Officer
Mar 1, 2022 04:05PM 10X Capital Venture Acquisition Corp. III Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing March 4, 2022
Mar 1, 2022 04:05PM 10X Capital Venture Acquisition Corp. III Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing March 4, 2022
Mar 1, 2022 01:27PM Form X-17A-5 CANTOR FITZGERALD & CO. For: Dec 31
Mar 1, 2022 12:34PM Amryt (AMYT) PT Lowered to $25 at Cantor Fitzgerald
Mar 1, 2022 10:35AM Cantor Fitzgerald Reiterates Amarin Corporation (AMRN) at Overweight, "Street is Underestimating Multi-billion Dollar Opportunity for Vascepa/Vazkepa"
Mar 1, 2022 08:29AM Novavax (NVAX) Stock Falls 6% on Weak Sales Guidance, Analyst Remains Positive
Mar 1, 2022 07:22AM Heron Therapeutics (HRTX) PT Lowered to $20 at Cantor Fitzgerald
Mar 1, 2022 06:58AM Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) at Overweight, Pharm Business is Underappreciated, Expect Upwards Earnings Revisions and Multiple Expansion
Mar 1, 2022 06:56AM Cantor Fitzgerald Reiterates Ardelyx (ARDX) at Overweight, Peak Sales Potential of Pipeline is Underappreciated
Mar 1, 2022 06:54AM Cantor Fitzgerald Reiterates Overweight Rating on Humanigen (HGEN), Expects Upward Earnings Revisions
Feb 25, 2022 05:00PM C5 Acquisition Corporation Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing February 28, 2022
Feb 25, 2022 06:40AM Cantor Fitzgerald Starts Journey Medical Corp. (DERM) at Overweight
Feb 24, 2022 06:05PM Katapult Holdings (KPLT) PT Lowered to $4 at Cantor Fitzgerald
Feb 24, 2022 05:19PM Delwinds Insurance Acquisition Corp. (DWIN) and FOXO Technologies Announce Merger Agreement
Feb 24, 2022 05:15PM FOXO Technologies Inc. Enters Into Business Combination Agreement with Delwinds Insurance Acquisition Corp.
Feb 24, 2022 05:15PM FOXO Technologies Inc. Enters Into Business Combination Agreement with Delwinds Insurance Acquisition Corp.
Feb 24, 2022 04:10PM Orchid Island Capital Announces Fourth Quarter 2021 Results
Feb 24, 2022 09:20AM Cantor Fitzgerald Reiterates Aclaris Therapeutis (ACRS) at Overweight, "Still a Lot of Value to be Unlocked in ACRS's Pipeline"
Feb 24, 2022 07:45AM Troika Media (TRKA) Acquires Converge Direct for $125M
Feb 24, 2022 07:45AM Troika Media Group to Acquire Converge Direct LLC, a Leading Digital and Offline Performance Media and Marketing Company, for $125 Million
Feb 24, 2022 07:45AM Troika Media Group to Acquire Converge Direct LLC, a Leading Digital and Offline Performance Media and Marketing Company, for $125 Million
Feb 24, 2022 07:45AM Troika Media Group to Acquire Converge Direct LLC, a Leading Digital and Offline Performance Media and Marketing Company, for $125 Million
Feb 24, 2022 06:20AM Cantor Fitzgerald Reiterates Overweight Rating on Vaxcyte (PCVX), VAX-24 Study Patient Dosing Brings the Company Closer to Potential Commercialization
Feb 23, 2022 04:15PM William Ferri Joins Cantor Fitzgerald to Lead Expansion of Asset Management Platform
Feb 23, 2022 06:36AM UPDATE: Cantor Fitzgerald Starts Affimed Therapeutics (AFMD) at Overweight
Feb 23, 2022 05:45AM Arcutis (ARQT) Reiterated at Overweight by Cantor Fitzgerald, Company's Opportunity to Become Medical Dermatology Leader Remains Underappreciated
View More Recent Stories View Older Stories